The Simms/Mann - UCLA Center for Integrative Oncology is part of UCLA's Jonsson Comprehensive Cancer Center and UCLA Oncology. To find out more about research opportunities and medical oncology care, please visit these sites.
simmsmanncenter@mednet.ucla.edu

Posts

Phone: (310) 794-6644 Fax: (310) 794-9615
Mon - Fri: 8:00AM - 5:00PM Sat - Sun: Closed
Email simmsmanncenter@mednet.ucla.edu

Insights Into Cancer – July 14, 2015

Colorectal Cancer: Recent Advances in Detection and Treatment

Presented by Zev Wainberg, MD

About the Lecture

Colorectal cancer continues to be a significant and frequently occurring disease with over 150,000 cases diagnosed annually. For an individual patient, the diagnosis of colorectal cancer is always a life-altering, frightening experience. New treatments are being investigated at a rapid pace and biomarkers are being validated which advise about the most appropriate therapies. The circumstances can often be overwhelming and difficult for those affected by colon cancer. Dr. Wainberg helps demystify the complexity by clarifying the basic approach to systemic colon and rectal cancer management and shedding light on some important controversies. Clinical trials of chemotherapy and targeted agents are an important resource for patients to access the latest novel treatments and he outlines some of the trials that are ongoing and the results of the most recent trials. The goal of this presentation is to help patients and their families understand the disease, treatment options and new approaches and how to apply them to the individual patient with colorectal cancer.

About the Speaker

Zev Wainberg, MD is an Assistant Professor in the Department of Medicine, Division of Hematology/Oncology at the David Geffen School of Medicine UCLA. As a medical oncologist who specializes in gastrointestinal cancers, Dr. Wainberg has an active practice and has many clinical trials devoted to these diseases. He is actively involved in designing and leading multiple clinical trials that are aimed at identifying the right patient populations for colorectal cancer therapies.

Contact us for more information or book an appointment